Showing 1,941 - 1,960 results of 103,428 for search '(( 5 ((c decrease) OR (a decrease)) ) OR ( 5 ((we decrease) OR (mean decrease)) ))', query time: 1.97s Refine Results
  1. 1941

    Light-emitting diode generated red light (LED-RL) at a fluence of 480 J/cm<sup>2</sup> significantly decreased relative fibroblast migration speed to 83.0±5.6% (p = 0.0393) compared to matched controls (100±5.8%). by Andrew Mamalis (5665591)

    Published 2015
    “…Error bars represent standard error of the mean. (* represents P < .05). Fig 3C. Light-emitting diode generated red light (LED-RL) at a fluence of 800 J/cm<sup>2</sup> significantly decreased relative fibroblast migration speed to 68.6±4.5% (p = 0.0003) compared to matched controls (100±4.2%). …”
  2. 1942
  3. 1943
  4. 1944
  5. 1945
  6. 1946

    <i>ogt-1; eel-1 +</i> Pan-neuronal OGT-1 have decreased sensitivity to electroshock and improved locomotion. by Nirthieca Suthakaran (11731101)

    Published 2021
    “…<p>Shown are each genotype ran through the electroconvulsive seizure assay for 3 seconds at 47V in saline control group. (A) Average time of recovery was significantly decreased in <i>ogt-1; eel-1</i> + Pan-neuronal OGT-1 worms, <i>Ogt-1(ok430) III; eel-1(bgg1) IV; bggSi2[Prab-3</i>::<i>ogt-1a] II</i> (n = 33), in comparison to <i>ogt-1;eel-1</i> double mutants (n = 30) but not significantly different from <i>eel-1</i> null mutants (n = 26). …”
  7. 1947
  8. 1948
  9. 1949
  10. 1950

    OSU-HDAC-44 decreased RhoA activity via srGAP1 induction, leading to F-actin dysregulation. by Yen-An Tang (187547)

    Published 2010
    “…<p>(<b>A</b>) Chromatin-immunoprecipitation-PCR analyses confirmed that treatment with 2.5 µM OSU-HDAC-44 for 2 h induced acetylation of histone H3 (H3K9K14Ac) in the promoter region of <i>srGAP1</i>, <i>NR4A1</i> and <i>FOXO4</i> genes. …”
  11. 1951
  12. 1952
  13. 1953
  14. 1954

    Efficacy and Acceptability of Glycemic Control of Glucagon-Like Peptide-1 Receptor Agonists among Type 2 Diabetes: A Systematic Review and Network Meta-Analysis by Zhixia Li (2736331)

    Published 2016
    “…Dulaglutide, exenatide long-acting release (exe_lar), liraglutide and taspoglutide had significant lowering effect when compared with sitagliptin (HbA1c<7.0%) and insulin (HbA1c<6.5%). Finally, according to SUCRAs, placebo, thiazolidinediones and albiglutide had the best decrease effect on hypoglycemia; sulphanylureas, sitagliptin and insulin decrease the incidence of treatment discontinuation most; exe_lar and dulaglutide had the highest impact on glycemic level among 13 treatments.…”
  15. 1955
  16. 1956
  17. 1957
  18. 1958
  19. 1959
  20. 1960